Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03982264
Other study ID # NFEC-2017-077
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 20, 2019
Est. completion date December 20, 2021

Study information

Verified date June 2019
Source Nanfang Hospital of Southern Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cap-assisted endoscopic mucosal resection (EMR-C) and endoscopic submucosal dissection (ESD) have both been reported to be effective treatment methods for small rectal neuroendocrine tumor (NET) in limited studies. Which one is better has not been determined. We aimed to compare the efficacy and safety of EMR-C and ESD for the treatment of small rectal NET.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date December 20, 2021
Est. primary completion date December 20, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Age from 18 to 75 years;

- Definite diagnosis of rectal NET less than 10mm;

- Patients plan to receive either EMR-C or ESD treatment.

Exclusion Criteria:

- Serious comorbid diseases such as advanced malignant tumor and organ failure;

- Patients received conventional EMR, snare electrotomy and no treatment;

- Rectal NET with metastasis;

- Pregnant patient;

- Poor compliance

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ESD procedure
ESD were all performed as the standard procedure that has been widely described and used. A diluted sodium hyaluronate solution was injected submucosally. Mucosal incision and submucosal dissection were performed by using either Hook knife (Olympus Medical, Japan) or a dual-knife (Olympus Medical, Japan) . After the resection was finished, all of the visible vessels on the artificial ulcer bed were thoroughly coagulated with argon plasma coagulation to prevent postoperative bleeding.
EMR-C procedure
A transparent cap (MH-593; Olympus) was attached to the forward-viewing endoscope. After the endoscope was inserted to the rectum, the snare passed through the sheath and was looped along the inner lip of the cap. The tumor was then suctioned into the cap and the snare was pushed off and closed. After confirming the appropriate snare placement, both the tumor and the overlying mucosa were resected by electric cautery (Endocut Q, effect 2, VIO 200D; ERBE, Tübingen, Germany), and then the removed tumor was sent for pathological examination. Endoscopic examination then was repeated without the transparent cap in order to evaluate the wound carefully in case there was any perforation or bleeding and to ensure the absence of the residual tumor tissues. If there was spurting bleeding or active bleeding, hot forceps were usually to stop the bleeding.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Nanfang Hospital of Southern Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary complete resection rate(R0 rate) Complete resection was defined as negative horizontal and vertical margins of specimen. within 14 days after procedure
Secondary operating time the time from endoscope in to endoscope out intraoperative
Secondary complications rate Complications were defined as perforation or hemorrhage during or after operation. within 14 days after procedure
Secondary length of stay calculated from the day of admission to day of discharge within 14 days after procedure
Secondary hospitalization cost represent the hospital's costs of being hospitalized within 14 days after procedure
Secondary recurrence rate a new rectal NET recurred confirmed by endoscopy and EUS one year after procedure
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05429216 - Endoscopic Resection for Small Rectal Neuroendocrine Tumors N/A